We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+1.66%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$13.6B
AUM Growth
+$707M
Cap. Flow
+$637M
Cap. Flow %
4.67%
Top 10 Hldgs %
16.72%
Holding
1,536
New
80
Increased
564
Reduced
430
Closed
56

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$69.2M
2
PEP icon
PepsiCo
PEP
+$63.3M
3
V icon
Visa
V
+$52.8M
4
PYPL icon
PayPal
PYPL
+$49.2M
5
WMT icon
Walmart Inc
WMT
+$47.4M

Sector Composition

Rank Sector Weight
1 Technology 20.44%
2 Healthcare 15.57%
3 Financials 13.68%
4 Consumer Discretionary 9.83%
5 Industrials 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAR icon
1451
Avis
CAR
$5.26B
$15K ﹤0.01%
545
ESRT icon
1452
Empire State Realty Trust
ESRT
$1.02B
$15K ﹤0.01%
1,063
HEI icon
1453
HEICO Corp
HEI
$49.2B
$15K ﹤0.01%
119
EPD icon
1454
Enterprise Products Partners
EPD
$83.6B
$14K ﹤0.01%
500
-900
-64% -$26.2K
LILA icon
1455
Liberty Latin America Class A
LILA
$1.67B
$14K ﹤0.01%
1,279
BBAR icon
1456
BBVA Argentina
BBAR
$3.84B
$13K ﹤0.01%
2,979
-1,521
-34% -$11.8K
RGNX icon
1457
Regenxbio
RGNX
$611M
$13K ﹤0.01%
370
-10,552
-97% -$428K
BFX
1458
DELISTED
BowFlex Inc.
BFX
$13K ﹤0.01%
9,712
HRTX icon
1459
Heron Therapeutics
HRTX
$92.5M
$10K ﹤0.01%
550
+150
+38% +$2.76K
MNDT
1460
DELISTED
Mandiant, Inc. Common Stock
MNDT
$8K ﹤0.01%
600
-1,400
-70% -$19.9K
CRSP icon
1461
CRISPR Therapeutics
CRSP
$4.63B
$7K ﹤0.01%
165
-1,035
-86% -$49.5K
CPL
1462
DELISTED
CPFL Energia S.A.
CPL
$7K ﹤0.01%
420
SRCI
1463
DELISTED
SRC Energy Inc
SRCI
$7K ﹤0.01%
1,578
SLCA
1464
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$6K ﹤0.01%
661
SIG icon
1465
Signet Jewelers
SIG
$3.8B
$5K ﹤0.01%
274
SITC icon
1466
SITE Centers
SITC
$235M
$5K ﹤0.01%
445
CLDR
1467
DELISTED
Cloudera, Inc.
CLDR
$5K ﹤0.01%
605
-895
-60% -$6.21K
ARLO icon
1468
Arlo Technologies
ARLO
$1.56B
$4K ﹤0.01%
1,039
IOVA icon
1469
Iovance Biotherapeutics
IOVA
$2.02B
$4K ﹤0.01%
220
CBUS icon
1470
Cibus
CBUS
$150M
$2K ﹤0.01%
8
-72
-90% -$28.7K
SGMO
1471
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2K ﹤0.01%
170
-1,130
-87% -$12.7K
ZYME icon
1472
Zymeworks
ZYME
$1.61B
$2K ﹤0.01%
+85
New +$2.13K
MRNS
1473
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
308
-1,255
-80% -$10.1K
ADVM
1474
DELISTED
Adverum Biotechnologies
ADVM
$1K ﹤0.01%
21
-199
-90% -$22.4K
AQB icon
1475
AquaBounty Technologies
AQB
$4.73M
$1K ﹤0.01%
21
-154
-88% -$9.54K

Similar funds

KBC Group's Q3 2019 Portfolio in Review

As of Q3 2019, KBC Group held 1,536 positions worth $13.6B, up 5.5% from $12.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

KBC Group deployed $637M of net new capital in Q3 2019, opening 80 new positions and adding to 564 existing holdings. Its largest new stake was Factset: 43,791 shares worth $10.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Intel, an estimated $39.9M trimmed.

  • KBC Group's largest Q3 2019 buy was Factset: 43,791 shares worth $10.6M.
  • KBC Group added most to JPMorgan Chase in Q3 2019, an estimated $69.2M increase.
  • KBC Group's biggest Q3 2019 reduction was Intel, cutting an estimated $39.9M.
  • KBC Group fully exited Worldpay, Inc. in Q3 2019, selling an estimated $22.9M.
  • KBC Group's ten largest holdings make up 17% of its $13.6B portfolio in Q3 2019.
  • KBC Group opened 80 new positions and closed 56 in Q3 2019.
  • KBC Group's portfolio value rose 5.5% quarter-over-quarter to $13.6B.

Based on KBC Group's 13F filing for Q3 2019, filed 7 Nov 2019.